Phase 1 trial of pembrolizumab with SBRT in metastatic urothelial carcinoma

被引：1

作者：

Sundahl, N. ^{[1
]}

Rottey, S. ^{[2
]}

Decaestecker, K. ^{[3
]}

De Visschere, P. ^{[4
]}

De Maeseneer, D. ^{[2
]}

Reynders, D. ^{[5
]}

Meireson, A. ^{[6
]}

Goetghebeur, E. ^{[5
]}

Fonteyne, V. ^{[1
]}

Verbeke, S. ^{[7
]}

Brochez, L. ^{[6
]}

Ost, P. ^{[1
]}

机构：

[1] Univ Hosp Ghent, Radiat Oncol, Ghent, Belgium

[2] Univ Hosp Ghent, Med Oncol, Ghent, Belgium

[3] Univ Hosp Ghent, Urol, Ghent, Belgium

[4] Univ Hosp Ghent, Radiol, Ghent, Belgium

[5] Univ Ghent, Dept Appl Math Comp Sci & Stat, Ghent, Belgium

[6] Univ Hosp Ghent, Dermatol & Dermatol Res Unit, Ghent, Belgium

[7] Univ Hosp Ghent, Pathol, Ghent, Belgium

来源：

关键词：

D O I：

10.1016/S0167-8140(18)30992-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OC-0682

引用

页码：S357 / S358

页数：4